News from the Arab World
At the Nuseirat refugee camp in the middle Gaza Strip on Friday, three journalists were hurt when they were targeted by the Israeli occupation forces.
According to Palestinian sources, journalists Sami Barhoum, Ahmed Harb, and Sami Shehadeh were injured by Israeli shelling; Shehadeh’s foot was cut.
Source: Jordan News Agency
On Friday, settlers attacked the town of Al-Mughayir, east of Ramallah, and opened fire on several homes.
The head of the Al-Mughir Council, Amin Abu Aliya, said: Dozens of settlers attacked the town from the eastern side.
He stated that the settlers opened fire on several homes, causing confrontations to erupt with dozens of citizens.
He pointed out that a large number of settlers are present at the entrance to the town under the protection of the Israeli army, amid a state of anticipation and tension.
In conjunction with an ongoing war on Gaza, settlers increased their attacks in the West Bank, and the Israeli army escalated its operations. Which led to the death of 462 citizens, the injury of about 4,750, and the arrest of 8,145
Source: Maan News Agency
JERUSALEM: Around 30,000 Muslims performed Friday prayers at Jerusalem’s Al-Aqsa Mosque in occupied Jerusalem, said the Islamic Waqf (Endowment) Department.
An estimated 30,000 worshipers held the Friday prayers at the blessed al-Aqsa mosque despite the tightened restrictions and beefed-up military deployments at the holy site gates and across the Old City of Jerusalem.
The occupation police beefed up their presence in the Old City and the surrounding area, scrutinizing the identities of young men and inspecting them.
Source: Palestine news & Information Agency – WAFA
TUBAS: Two Palestinians were shot dead by the Israeli occupation forces early morning near Tubas in the northern West Bank.
Sources said that a Palestinian man was killed after Israeli forces opened gun fire at his vehicle in the city of Tubas.
Heavily armed soldiers raided the said city in the morning hours and deployed their forces across the streets and alleys.
Following their incursion, Israeli soldiers opened fire at the young man while he was inside his vehicle.
Later, the Red Crescent crews announced that they had recovered the body of the young man while he was inside the targeted vehicle after the occupation forces abandoned it near the Tammoun Junction, south of Tubas.
Another Palestinian, who was identified as Muhammad Shahmawi, was shot and killed from Israeli gunfire during their military incursion into the Al-Far’a camp, south of Tubas.
Source: Palestine news & Information Agency – WAFA
Israeli gunners on Friday bombarded Al-Nusairat camp in central Gaza wounding several journalists including one who lost a foot with the shells’ shrapnel.
The local authorities reported that photographer Sami Shehadeh lost a foot in the attacks that also wounded other journalists, namely Mohammad Al-Sawalhi and Ahmad Al-Loh.
They also said that the corpses of seven martyrs and 72 wounded Gazans were taken to hospitals amid artillery bombardment and air attacks on the shanty town.
Elsewhere, the occupation forces bulldozed the Palestine Bank building in Al-Zahraa, southwest Gaza, after burning it.
The occupation forces, meanwhile, continued the offensive on suspected strongholds of Hamas and Islamic Jihad around the Malaysian School and Al-Salhi Towers in Al-Nusairat camp.
The occupiers started a major raid into Al-Nusairat three days ago, killing scores of people, injuring many and demolishing a large number of buildings.
Earlier today, the Gaza authorities declared that the six-month-old Israeli aggre
ssion on Gaza resulted in killing 33,634 people and wounding 76,214 others
Source: Kuwait News Agency
RAMALLAH: Four Palestinians were injured this evening in an attack by colonists on the village of Abu Falah, northeast of Ramallah.
Local sources said that at least four Palestinian youth sustained injuries when a group of armed colonists sneaked into the said village.
The colonists further set several Palestinian-owned vehicles and homes on fire during the raid.
Source: Palestine news & Information Agency – WAFA
The Kuwaiti Relief Society has distributed meat to war-afflicted families in Gaza after the fasting month of Ramadan.
Omar Al-Thuwaini, the society’s deputy director general, said in remarks to KUNA on Friday that the society, in coordination with the charities “Wafa” and “Rahma,” distributed during the three-day Eid Al-Fitr 52 tons of meat to the poor, displaced families and those affected with the Israeli aggression on South Gaza.
The relief activity was supported by the State of Kuwait Al-Awqaf General Secretariat.
Meanwhile, “Wafa” director general Muhaisen Al-Atawneh, said 10,000 relocated families in the enclave received amounts of donated meat during the Eid. His peer at “Rahma,” Mohammad Qaddous, said Kuwait, since the start of the Israeli aggression in early October, has doubled the aid sent to Gaza via the air, the land and sent in medical teams to treat the injured.
Much of the aid supplies that had been sent to Gaza or dropped from the air were cereals. The meat had been scarce in the shell-d
evastated and beleaguered strip.
Source: Kuwait News Agency
Israeli occupation forces on Friday raided the town of Al-Maghir northeast of Ramallah and settlers killed one young Palestinian.
The Palestinian Ministry of Health said in a statement that the martyr, Jihad Abu Alya, was admitted at the Medical Palestice Complex in Ramallah. He had been shot by Jewish settlters who surrounded his house and opened fire at him.
The ministry added that 18 Palestinians were wounded in the occupation forces’ raid on Al-Maghir. Simultaneously, settlers attacked the town and opened fire at the residents and set vehicles ablaze.
Source: Kuwait News Agency
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
Mont-Saint-Guibert, Belgium – April 11, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Dr. Maurits S. Boon, MD as Chief Medical Officer.
Dr. Boon joins Nyxoah from the Thomas Jefferson University, where he will continue part time as a professor and Vice Chairman, Education. He is dual board-certified in otolaryngology – head and neck surgery, as well as sleep medicine. Dr. Boon is one of two sleep surgeons with Jefferson Health to pioneer the use of hypoglossal nerve stimulation therapy (HGNS) and is internationally recognized as one of the most experienced surgeons performing HGNS procedures. He has lectured worldwide on obstructive sleep apnea, has numerous publications and is co-editor of the first book on HGNS.
“As an academic physician who has dedicated my professional career to the care of patients with sleep disordered breathing, I was privileged to participate in the DREAM U.S. pivotal trial. I was initially impressed by the results I saw in my patients and then equally impressed by the data that were recently reported. As such, I am honored to have been offered a position to join Nyxoah at such an exciting time. Bilateral hypoglossal nerve stimulation with Genio has tremendous potential and I am thrilled to work with their talented team to make a meaningful impact on the lives of patients with obstructive sleep apnea,” commented Dr. Boon.
“I could not be more excited to have Dr. Boon join Nyxoah. He is one of the pioneers in hypoglossal nerve stimulation and his decision to become Nyxoah’s Chief Medical Officer reflects Genio’s ability to improve the lives of OSA patients,” commented Olivier Taelman, Chief Executive Officer. “Dr. Boon will play a critical role as we prepare to enter the U.S. market and achieve our mission of making sleep simple again.”
About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.
For more information, please visit http://www.nyxoah.com/.
Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.
Forward-looking statements
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and the Company’s results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2024, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.
Contacts:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313
Attachment
GlobeNewswire Distribution ID 1000934233